Altrubio Inc.

Altrubio Inc. company information, Employees & Contact Information

Explore related pages

Altrubio Inc. email format Altrubio Inc. management contacts

Related company profiles:

AltruBio is developing first-in-class immune-modulators targeting diseases of #immunology and #inflammation. Its world-class global team brings a breadth of expertise in immunology and drug development that will help advance their biologic treatments to patients. Learn more at https://www.altrubio.com/altrubio/en

Company Details

Employees
30
Founded
-
Address
505 Montgomery St,
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
https://www.altrubio.com/altrubio/en
Keywords
jobs.
HQ
San Francisco, California
Competitors
Formation Bio, Xaira Therapeutics, Element Biosciences, Pheon Therapeutics, Arsenal Biosciences, Inc., Cytokinetics, Alumis, Dyne Therapeutics, Cardurion Pharmaceuticals, Uniquity Bio.
Looking for a particular Altrubio Inc. employee's phone or email?

Altrubio Inc. Questions

News

VC-Funded Life Sciences Companies in the Bay Area - The Business Journals

VC-Funded Life Sciences Companies in the Bay Area The Business Journals

AltruBio Announces Formation of Scientific Advisory Board - BioSpace

AltruBio Announces Formation of Scientific Advisory Board BioSpace

AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program - Yahoo Finance

AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program Yahoo Finance

AltruBio lands up to $225M after shift to immune drug research - BioPharma Dive

AltruBio lands up to $225M after shift to immune drug research BioPharma Dive

AltruBio raises $225 million to develop ulcerative colitis drug and other immune checkpoint enhancers - statnews.com

AltruBio raises $225 million to develop ulcerative colitis drug and other immune checkpoint enhancers statnews.com

AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program - Fierce Biotech

AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program Fierce Biotech

AltruBio Raises $63 Million Series A Round To Continue Its Company Transformation - GlobeNewswire

AltruBio Raises $63 Million Series A Round To Continue Its Company Transformation GlobeNewswire

AltruBio doses first subject in Phase I ulcerative colitis therapy trial - Clinical Trials Arena

AltruBio doses first subject in Phase I ulcerative colitis therapy trial Clinical Trials Arena

Investment Surges in Immunology Boost AltruBio’s Prospects - The Healthcare Technology Report.

Investment Surges in Immunology Boost AltruBio’s Prospects The Healthcare Technology Report.

AltruBio: $225 Million Raised To Develop Novel Therapeutics For Treating Immunological Diseases With Unmet Medical Needs - Pulse 2.0

AltruBio: $225 Million Raised To Develop Novel Therapeutics For Treating Immunological Diseases With Unmet Medical Needs Pulse 2.0

AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate - BioSpace

AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate BioSpace

The Week’s 10 Biggest Funding Rounds: Scale AI’s Massive $1B Deal Leads Slower Week - Crunchbase News

The Week’s 10 Biggest Funding Rounds: Scale AI’s Massive $1B Deal Leads Slower Week Crunchbase News

New name, new board, new focus: AltruBio relaunches with $63M series A - Fierce Biotech

New name, new board, new focus: AltruBio relaunches with $63M series A Fierce Biotech

Former Bayer, Genentech exec's biotech raises $225 million to target ulcerative colitis - San Francisco Business Times - The Business Journals

Former Bayer, Genentech exec's biotech raises $225 million to target ulcerative colitis - San Francisco Business Times The Business Journals

AltruBio snags a CMO after pivot from oncology to immunology - Fierce Biotech

AltruBio snags a CMO after pivot from oncology to immunology Fierce Biotech

The Bay Area's most VC-funded life sciences companies by equity raised in 2024 - San Francisco Business Times - The Business Journals

The Bay Area's most VC-funded life sciences companies by equity raised in 2024 - San Francisco Business Times The Business Journals

Three Influential Women in Biopharma Explain How to Break the Executive Barrier - BioSpace

Three Influential Women in Biopharma Explain How to Break the Executive Barrier BioSpace

Chutes & Ladders—AltruBio snags new CMO with resume at Sublimity, Ardea, Amgen and Abbott - Fierce Biotech

Chutes & Ladders—AltruBio snags new CMO with resume at Sublimity, Ardea, Amgen and Abbott Fierce Biotech

Companies like Altrubio Inc.

Uniquity Bio logo - Similar company to Altrubio Inc.

Uniquity Bio

33
Formation Bio logo - Similar company to Altrubio Inc.

Formation Bio

180
Element Biosciences logo - Similar company to Altrubio Inc.

Element Biosciences

412
Pheon Therapeutics logo - Similar company to Altrubio Inc.

Pheon Therapeutics

29
Alumis logo - Similar company to Altrubio Inc.

Alumis

216
Arsenal Biosciences, Inc. logo - Similar company to Altrubio Inc.

Arsenal Biosciences,...

298
Cardurion Pharmaceuticals logo - Similar company to Altrubio Inc.

Cardurion Pharmaceut...

77
Xaira Therapeutics logo - Similar company to Altrubio Inc.

Xaira Therapeutics

174
Dyne Therapeutics logo - Similar company to Altrubio Inc.

Dyne Therapeutics

227
Cytokinetics logo - Similar company to Altrubio Inc.

Cytokinetics

634

Top Altrubio Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant